Skip to main content
Premium Trial:

Request an Annual Quote

New Products Posted to GenomeWeb: Thermo Fisher, ImmunoIVD, NanoView Biosciences, More

Thermo Fisher Scientific MagMAX Wastewater Ultra Nucleic Acid Isolation Kit

Thermo Fisher Scientific has launched the MagMAX Wastewater Ultra Nucleic Acid Isolation Kit. The kit is meant to support the efforts of public health laboratories and researchers who have been developing SARS-CoV-2 surveillance methods using wastewater to help identify asymptomatic carriers on college campuses, monitor regional spread among communities, and capture emerging viral mutations, the company said.

The MagMAX Wastewater Ultra Nucleic Acid Isolation Kit is compatible with a range of input volumes from 200 µl to 500 mL, and works with various upfront concentration methods, including ultracentrifugation, precipitation, and filtration. For labs in need of an automated viral enrichment method, the MagMAX Wastewater Ultra Nucleic Acid Isolation Kit with virus enrichment uses Dynabeads technology to automate and streamline sample concentration.

ImmunoIVD SPOT-it TREC & SMN1 Screening Kit

ImmunoIVD, a Stockholm-based diagnostic company specializing in severe combined immunodeficiency (SCID) newborn screening, has launched the CE IVD marked SPOT-it TREC & SMN1 Screening Kit in the EU. The real-time qPCR assay is designed to simultaneously screen for SCID and spinal muscular atrophy (SMA) in newborns using DNA extracted from fresh, dried blood spots sampled on filter paper. The assay is based on the same plate-stacking procedure as the SPOT-it SCID screening assays, making it efficient and affordable for small to medium-sized screening laboratories, a company spokesperson said. SCID screening is performed by semi-quantification of T-cell receptor excision circle, while SMA screening is performed through the qualitative detection of exon 7 of the SMN1 gene, according to the company's website.

NanoView Biosciences Release ExoView R200 Platform

NanoView Biosciences has released its next-generation NanoView R200 platform for the detection and characterization of extracellular vesicles (EVs), including exosomes and viruses. Similar to the original R100 platform, launched in 2019, the R200 platform delivers EV sizing down to 50 nm and requires low sample input, no extensive sample preparation or purification, and minimal hands-on time. Additionally, the new features of the R200 include near-infrared fluorescence channels (five channels total), EV concentration measurement, higher throughput, large particle analysis, faster scan times, and fully automated sample loading and processing.

For more new products and services, please visit the New Products page on our website.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.